Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018
May 10 2018 - 8:33AM
Bioanalytical Systems, Inc. (NASDAQ:BASI)
(“BASi” or the “Company”) today announced that it
will report financial results for the second quarter and six months
ended March 31, 2018, prior to the market opening on Tuesday, May
15, 2018.
If there are any questions after the press release is issued,
please direct your comments to the investor relations contact noted
in this release.
About Bioanalytical Systems,
Inc.
BASi is a pharmaceutical development company
providing contract research services and monitoring instruments to
the world's leading drug development companies and medical research
organizations. The Company focuses on developing innovative
services and products that increase efficiency and reduce the cost
of taking a new drug to market. Visit www.BASinc.com for more
information about BASi.
This release may contain forward-looking
statements that are subject to risks and uncertainties including,
but not limited to, risks and uncertainties related to changes in
the market and demand for our products and services, the
development, marketing and sales of products and services, changes
in technology, industry standards and regulatory standards, and
various market and operating risks detailed in the company's
filings with the Securities and Exchange Commission.
FOR MORE INFORMATION:
Company Contact:Jill
BlumhoffChief Financial Officer & Vice President of
Finance Phone: 765.497.8381
jblumhoff@BASinc.com
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Apr 2023 to Apr 2024